Search results
Found 189 matches for
An international team of researchers have been presented with medals for their work combating Ebola in West Africa. All were involved in efforts to find an effective treatment for the Ebola virus.
AIMday in Women's Health - registration for academics now open
Events Innovation
8 April 2021
Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.
Innovation award for Professor Anindita Roy to develop new treatments for childhood cancer
Awards and Appointments General Innovation Research
18 March 2021
Associate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of £4.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children’s and young people’s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
Oxford vaccine creator Professor Sarah Gilbert awarded RSA Albert Medal
Awards and Appointments Coronavirus COVID-19 General Innovation Research
5 March 2021
Professor Sarah Gilbert has been awarded the Royal Society for Arts, Manufactures and Commerce’ (RSA) Albert Medal for her work on the Oxford vaccine.
Singula Bio, a new Oxford spin-out company - Cancer need not be fatal
General Innovation Research
25 February 2021
Singula Bio, a bold new seed-stage biotechnology company spun out of Oxford University, has been launched with the intention of helping show that cancer need not be fatal. Led by three Oxford cancer specialists, the firm is aims to become a world leader in therapies to use against difficult-to-treat solid malignancies such as ovarian cancer - using the body’s own immune system to fight previously fatal cancers.
Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders
General Innovation
16 February 2021
The University of Oxford announced today that it has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
BioEscalator’s Enara Bio partners with Boehringer Ingelheim to develop novel cancer immunotherapies
General Innovation
4 February 2021
Enara Bio, a start-up located in the University’s BioEsclator, has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim, worth over €876M (£787M), to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.
Investigating New Treatment for Schizophrenia
General Innovation Research
21 January 2021
A partnership between University of Oxford, the Earlham Institute, and the global pharmaceutical companies Biogen Inc and Boehringer Ingelheim is announced today to investigate a new drug target for the treatment of schizophrenia.
£100 million donation from Ineos to create new institute to fight antimicrobial resistance
Awards and Appointments General Innovation
19 January 2021
A new state of the art institute for antimicrobial research is to open at Oxford University thanks to a £100 million donation from Ineos.
University spinout PepGen awarded major financing to target Duchenne muscular dystrophy
Awards and Appointments General Innovation
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
Evox Therapeutics announces launch of strategic collaboration with the University of Oxford
General Innovation
18 November 2020
Collaboration with world-renowned research centre to accelerate development of exosome therapies for rare diseases
BioEscalator’s resident biotech Base Genomics acquired by Exact Sciences
General Innovation
4 November 2020
Oxford Sciences Innovation (OSI) recently announced the acquisition of its portfolio company, Base Genomics, by US-based early cancer diagnostic leaders, Exact Sciences, for $410m. The partnership will enable Base Genomics to significantly accelerate its clinical and commercial development here in Oxford, potentially unlocking a new era of preventative medicine and improved patient outcomes.
Novel COVID-19 Antibody Therapy Candidates Identified by Leading UK Biotech Consortium
Coronavirus COVID-19 Innovation Research
29 October 2020
Comparison of five tests used to detect COVID-19 antibodies shows Siemens and Oxford assays met regulatory targets
Coronavirus COVID-19 Innovation Research
28 September 2020
New research shows that, in a head-to-head comparison of five tests used to detect COVID-19 antibodies (known as ‘immunoassays’), an assay manufactured by Siemens and one developed by an academic partnership led by the University of Oxford had the most accurate results. The study is published in The Lancet Infectious Diseases.
QUOD enters partnership with Evotec
General Innovation Research
2 September 2020
Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.
Professor Fran Platt secures £1M funding over two years for vital Parkinson's Disease research, in collaboration with Pfizer
Awards and Appointments General Innovation Research
4 August 2020
There is an increasing body of genetic and biochemical evidence that points toward lysosomal dysfunction as a risk factor for developing age-related neurodegenerative disorders, including Parkinson’s disease (PD).
Agile start-ups partner with academics to find COVID-19 solutions
Coronavirus COVID-19 General Innovation Research
16 July 2020
Three companies at Oxford’s BioEscalator are developing new detection methods and have discovered potential therapeutics in the fight against COVID-19.
Oxford University to lead a new national programme of AI research to improve lung cancer screening
General Innovation Research
3 July 2020
UK Research and Innovation, Cancer Research UK and industry are investing more than £11 million in an Oxford-led artificial intelligence (AI) research programme to improve the diagnosis of lung cancer and other thoracic diseases.
Ebola vaccine approved for use by the European Commission
General Innovation Research
2 July 2020
The European Commission has granted Marketing Authorisation to Janssen for a new Ebola vaccine, developed in partnership with the University of Oxford.
Theolytics announced winners of the Santander Pitch Finale
General Innovation
24 June 2020
Following a fantastic event, Theolytics was announced the winner of the BioEscalator’s inaugural Pitch Finale, which was kindly supported by Santander Universities UK.
New partnership aims to significantly reduce the incidence of hip and vertebral fractures
General Innovation Research
16 June 2020
The Capture the Fracture Partnership aims to prevent 250 million fractures by 2025 and combat the global public health burden of osteoporosis.